Quote | Mainz Biomed B.V. (NASDAQ:MYNZ)
Last: | $0.7367 |
---|---|
Change Percent: | -3.37% |
Open: | $0.7909 |
Close: | $0.7367 |
High: | $0.795 |
Low: | $0.72 |
Volume: | 169,563 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
News | Mainz Biomed B.V. (NASDAQ:MYNZ)
Groundbreaking topline results demonstrated sensitivity for colorectal cancer of 92% with specificity of 90% and best-in-class sensitivity for advanced adenoma of 82% 690 subjects analyzed including previously unexamined and reported patients from Company’s ColoFuture and eAArl...
BERKELEY, Calif. and MAINZ, Germany, April 09, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a leader in molecular genetics diagnostic solutions for early cancer detection, announced today financial results for the fisc...
Message Board Posts | Mainz Biomed B.V. (NASDAQ:MYNZ)
Subject | By | Source | When |
---|---|---|---|
Looks pretty positive | budfoxfun | investorshub | 04/27/2023 10:08:15 PM |
$MYNZ The now | cuggegrosse | investorshub | 04/27/2023 6:07:40 PM |
Thoughts on where this is headed? | Mrogers23 | investorshub | 04/27/2023 5:51:00 PM |
That cat bounced. Poped back over $4. | BooDog | investorshub | 04/27/2023 2:31:33 PM |
$MYNZ The now last up | BlazingStocks | investorshub | 04/27/2023 11:42:39 AM |
News, Short Squeeze, Breakout and More Instantly...
Mainz Biomed B.V. Company Name:
MYNZ Stock Symbol:
NASDAQ Market:
Groundbreaking topline results demonstrated sensitivity for colorectal cancer of 92% with specificity of 90% and best-in-class sensitivity for advanced adenoma of 82% 690 subjects analyzed including previously unexamined and reported patients from Company’s ColoFuture and eAArl...
Bristol Myers Squibb (NYSE: BMY), Merck & Co Inc (NYSE: MRK), Pfizer Inc (NYSE: PFE) and Johnson & Johnson(NYSE: JNJ) a...
BERKELEY, Calif. and MAINZ, Germany, April 09, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a leader in molecular genetics diagnostic solutions for early cancer detection, announced today financial results for the fisc...